Leiomyosarcoma NOS (LMS) 8890/3
UZLX-STS22
(Synonyms: -)
HUSARC Accession Number: HU-23.29
unknown
- no data online available
If you are interested in a model, please contact the corresponding researcher directly (contact information can be found below and in the datasheet).
- Cornillie J, Wozniak A, Li H, Wang Y, Boeckx B, Gebreyohannes YK, Wellens J, Vanleeuw U, Hompes D, Stas M, Sinnaeve F, Wafa H, Lambrechts D, Debiec-Rychter M, Sciot R, Schöffski P. Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing. Mol Cancer Ther. 2019 Jun;18(6):1168-1178. doi: 10.1158/1535-7163.MCT-18-1045. Epub 2019 Apr 8. PMID: 30962320.
- Cornillie J, Wozniak A, Van Renterghem B, Van Winkel N, Wellens J, Gebreyohannes YK, Debiec-Rychter M, Sciot R, Hompes D, Schöffski P. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts. BMC Cancer. 2019 Jul 22;19(1):724. doi: 10.1186/s12885-019-5872-1. PMID: 31331295; PMCID: PMC6647161.
Entry creation: 27.01.2023
Last entry update: 27.01.2023
Version number: #1